CD4 Immunoadhesins: Clinical Trials

6 trials of CD4 Immunoadhesins, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 5 Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Not applicable1Completed 1

Follow CD4 Immunoadhesins: new trials by email Literature Review of CD4 Immunoadhesins trials Research Report on CD4 Immunoadhesins

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex
CD4-IgG - HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)602005-06-24
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex
CD4-IgG, Zidovudine - HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)402008-08-06
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection
CD4-IgG - HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)182005-06-24
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns
CD4-IgG - HIV Infections, Pregnancy
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)302005-06-24
A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura
CD4-IgG - Immune Thrombocytopenic Purpura ( ITP ), HIV Infections
Phase 1CompletedGenentech, Inc.2005-06-24
An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection
CD4-IgG, Zidovudine, Interferon alfa-n1 - HIV Infections
Not applicableCompletedNational Institute of Allergy and Infectious Diseases (NIAID)62021-10-27

Conditions studied

HIV Infections (6)  ·  Acquired Immunodeficiency Syndrome (4)  ·  AIDS-Related Complex (2)  ·  Pregnancy Complications, Infectious (1)  ·  Purpura, Thrombocytopenic, Idiopathic (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (5)  ·  Genentech, Inc. (1)

Countries

United States (6)

Top investigators

A Collier (1)  ·  D Richman (1)  ·  KM Zunich (1)  ·  L Corey (1)  ·  M Fischl (1)  ·  R Yogev (1)  ·  W Shearer (1)